Cumulative Cost of Treatment with ILUVIEN (Fluocinolone Acetonide [FAC]) Versus the Current Standard of Care in the Treatment of Visual Impairment Due to Diabetic Macular Oedema (DMO) in Phakic Eyes Over a 3 Year Period- An Analysis from a ...
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1260
https://www.valueinhealthjournal.com/article/S1098-3015(16)32626-2/fulltext
Title :
Cumulative Cost of Treatment with ILUVIEN (Fluocinolone Acetonide [FAC]) Versus the Current Standard of Care in the Treatment of Visual Impairment Due to Diabetic Macular Oedema (DMO) in Phakic Eyes Over a 3 Year Period- An Analysis from a ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32626-2&doi=10.1016/j.jval.2016.09.1260
First page :
A564
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1181